Skip to main content

Table 1 Baseline Characteristics of the Patients in the Groups

From: Different doses of nalmefene combined with hydromorphone hydrochloride for postoperative analgesia after colorectal surgery: a randomized controlled study

 

Group N1

(2 µg/kg)

(n = 31)

Group N2

(0.5 µg/kg)

(n = 31)

Group C

(n = 31)

F value

χ2 value

P value

Sex, female/male

17/14

14/17

12/19

 

1.644

0.44

Age (year, \(\bar x \pm s\))

61 ± 12

59 ± 12

61 ± 12

0.169

 

0.845

Height (cm, \(\bar x \pm s\))

164 ± 8

165 ± 9

167 ± 6

1.542

 

0.22

Weight (kg, \(\bar x \pm s\))

62 ± 13

66 ± 12

66 ± 11

1.233

 

0.296

ASA grade (I/II/III)

0/22/9

0/26/5

0/24/7

 

1.476

0.478

Transfusion volume (ml, \(\bar x \pm s\))

2337 ± 717

2114 ± 509

2484 ± 579

2.900

 

0.06

Blood loss (ml, \(\bar x \pm s\))

141 ± 138

141 ± 104

148 ± 122

0.04

 

0.961

Urine output (ml, \(\bar x \pm s\))

309 ± 264

247 ± 256

349 ± 323

1.026

 

0.363

Duration of surgery (h, \(\bar x \pm s\))

3.91 ± 0.76

3.70 ± 0.84

4.18 ± 0.80

2.866

 

0.062

Surgical type (laparoscopic/hand-assisted laparoscopic)

22/9

22/9

27/4

 

2.977

0.226